COVID-19 Research Funding

Last Updated January 27, 2021

External Funding Opportunities

Curated Pivot Search

National Institutes of Health (NIH)

National Science Foundation (NSF)

Patient-Centered Outcomes Research Institute

Corporate and Foundation Funders

Other Lists of Open Funding Opportunities

  • Frontiers, a leading open access publisher, has curated a list of open funding calls and other support for researchers, specifically related to COVID-19 and coronavirus-related research.

Assistance with Funding Searches

OVPR’s Research Enhancement Unit is available to assist investigators in locating appropriate funding mechanisms or refining Pivot searches. Email [email protected] to request a consultation.

Reminder: Limited Submission Opportunities

If a funding opportunity limits the number of submissions from each organization, please notify [email protected] immediately to expedite an internal review and selection process.

Review of Research Involving COVID-19

All of the standard protocol reviews apply to COVID-19 related studies and no new projects may commence without these approvals. However, GW’s review boards have implemented plans to speed the reviews of research protocols involving COVID-19.

  • The Institutional Biosafety Committee has released interim guidance for research involving COVID-19. The IBC will review applications within five business days. The IBC will convene by teleconference or videoconference as necessary to accommodate these submissions.
  • The Institutional Review Board is prioritizing review of these protocols by assembling a standing panel of reviewers that will convene as necessary. For new studies focusing on COVID-19 Essential Research, please include the term COVID in the study title, and follow the process for requesting rush review.
  • The Institutional Animal Care and Use Committee will continue to conduct official business during the COVID-19 pandemic. Alternatives to face-to-face meetings such as teleconference or video conferencing will be employed in order to ensure protocol approvals are not allowed to expire and that high priority submissions are approved within a timely manner.